Promising Early Results Reported for Russia’s Pioneer mRNA Melanoma Vaccine
Russian medical scientists have reported encouraging early clinical data from the trial of a locally developed mRNA-based cancer vaccine targeting advanced melanoma. According to researchers, the primary patient undergoing the novel treatment has developed a targeted immune response capable of combating malignant cells without experiencing severe adverse side effects. The bespoke therapeutic vaccine, named Neooncovac, […]
Read more